Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Consult your doctor to choose which may be better suited for you based on your medical history and needs
Detoxifying the body: It binds to harmful substances, helping the liver remove them efficiently
For type 2 diabetes patients with significant obesity, this comprehensive metabolic reset could potentially reduce or eliminate the need for multiple diabetes medications
The primary mechanism of action involves binding to GLP-1 receptors on pancreatic beta cells, which stimulates glucose-dependent insulin secretion
Medicare Part D Gross Spending on GLP-1s Increased Five-Fold Between 2019 and 2024, But Estimated Rebates of Around 50% Mean That Net Spending is Much Lower Gross Medicare Part D spending on GLP-1s in 2024 (not accounting for rebates) totaled $27.5 billion, a five-fold increase from 2019, reflecting an expansion in use of GLP-1s with more recent FDA approvals for type 2 diabetes
Dosing Research Parameters In the published clinical studies, retatrutide was administered once weekly by subcutaneous injection
